Eva Renee Barnett

Insider Reports History

Location
New York, NY
Signature
/s/ Eva Renee Barnett
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eva Renee Barnett:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Chief Financial Officer Common Stock 396,774 $5,907,965 $14.89 16 Apr 2025 Direct
Immunovant, Inc. Chief Financial Officer Stock Option (right to buy) 125,180 01 Apr 2025 Direct

Insider Reports Filed by Eva Renee Barnett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMVT Immunovant, Inc. 16 Apr 2025 1 -$44,566 4 Chief Financial Officer 17 Apr 2025, 16:08
IMVT Immunovant, Inc. 09 Apr 2025 2 -$143,708 4 Chief Financial Officer 11 Apr 2025, 16:06
IMVT Immunovant, Inc. 01 Apr 2025 2 $0 4 Chief Financial Officer 03 Apr 2025, 16:48
IMVT Immunovant, Inc. 19 Feb 2025 1 -$58,700 4 Chief Financial Officer 21 Feb 2025, 16:05
IMVT Immunovant, Inc. 15 Jan 2025 2 -$54,757 4 Chief Financial Officer 17 Jan 2025, 16:05
IMVT Immunovant, Inc. 08 Jan 2025 1 -$98,930 4 Chief Financial Officer 10 Jan 2025, 16:12
IMVT Immunovant, Inc. 20 Nov 2024 1 -$106,228 4 Chief Financial Officer 22 Nov 2024, 16:09
IMVT Immunovant, Inc. 16 Oct 2024 1 -$94,172 4 Chief Financial Officer 18 Oct 2024, 16:27
IMVT Immunovant, Inc. 09 Oct 2024 1 -$152,589 4 Chief Financial Officer 11 Oct 2024, 16:04
IMVT Immunovant, Inc. 21 Aug 2024 2 -$120,045 4 Chief Financial Officer 23 Aug 2024, 16:11
IMVT Immunovant, Inc. 17 Jul 2024 2 -$92,733 4 Chief Financial Officer 19 Jul 2024, 17:39
IMVT Immunovant, Inc. 09 Jul 2024 1 -$133,201 4 Chief Financial Officer 10 Jul 2024, 17:07
IMVT Immunovant, Inc. 22 May 2024 1 -$119,845 4 Chief Financial Officer 24 May 2024, 16:18
IMVT Immunovant, Inc. 17 Apr 2024 2 -$356,049 4 Chief Financial Officer 19 Apr 2024, 18:01
IMVT Immunovant, Inc. 09 Apr 2024 1 -$115,023 4 Chief Financial Officer 10 Apr 2024, 16:18
IMVT Immunovant, Inc. 02 Apr 2024 2 $0 4 Chief Financial Officer 04 Apr 2024, 16:27
IMVT Immunovant, Inc. 22 Feb 2024 1 -$105,920 4 Chief Financial Officer 23 Feb 2024, 16:21
IMVT Immunovant, Inc. 11 Jan 2024 2 -$147,023 4 Chief Financial Officer 12 Jan 2024, 16:34
IMVT Immunovant, Inc. 22 Nov 2023 2 -$132,920 4 Chief Financial Officer 24 Nov 2023, 14:51
IMVT Immunovant, Inc. 10 Oct 2023 1 -$168,244 4 Chief Financial Officer 11 Oct 2023, 16:11
IMVT Immunovant, Inc. 24 Aug 2023 2 -$292,036 4 Chief Financial Officer 25 Aug 2023, 18:03
IMVT Immunovant, Inc. 19 Jul 2023 1 -$67,962 4 Chief Financial Officer 20 Jul 2023, 16:35
IMVT Immunovant, Inc. 18 Apr 2023 1 -$52,269 4 Chief Financial Officer 19 Apr 2023, 16:15
IMVT Immunovant, Inc. 12 Apr 2023 2 $0 4 Chief Financial Officer 14 Apr 2023, 16:22
IMVT Immunovant, Inc. 11 Jan 2023 2 -$75,525 4 Chief Financial Officer 13 Jan 2023, 07:16
IMVT Immunovant, Inc. 11 Oct 2022 1 -$118,000 4 Chief Financial Officer 13 Oct 2022, 16:20
IMVT Immunovant, Inc. 17 Aug 2022 2 $0 4 Chief Financial Officer 19 Aug 2022, 16:52
IMVT Immunovant, Inc. 07 Jan 2022 1 -$217,203 4 Chief Financial Officer 11 Jan 2022, 09:53
IMVT Immunovant, Inc. 15 Oct 2021 2 $0 4 Chief Financial Officer 18 Oct 2021, 17:11
IMVT Immunovant, Inc. 04 Oct 2021 1 $0 4 Chief Financial Officer 05 Oct 2021, 12:07
IMVT Immunovant, Inc. 04 Oct 2021 0 $0 3 Chief Financial Officer 05 Oct 2021, 12:04